SCHEMBL25664483

SCHEMBL25664483

Cc1nc(CO)c(Cl)cc1C1OCCO1

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23726539 0.82 NPC1 (0.43) NPC1RAB9A
SCHEMBL25664480 0.73 NPC1 (0.38) NPC1RAB9A
SCHEMBL25664484 0.73 NPC1 (0.39) NPC1RAB9A
SCHEMBL25664481 0.71 NPC1 (0.46) NPC1RAB9A
SCHEMBL25664239 0.70 DRD2 (0.33)
SCHEMBL334839 0.69 GLP1R (0.31)
SCHEMBL30513555 0.67 NPC1 (0.48) NPC1RAB9A
SCHEMBL20876602 0.67 NPC1 (0.48) NPC1RAB9A
SCHEMBL10436530 0.66 SLC6A4 (0.38) NPC1RAB9A
SCHEMBL23725138 0.65 NPC1 (0.40) NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL NPC1 165/4885RAB9A 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.